191 related articles for article (PubMed ID: 18499211)
41. Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency.
Assogba BD; Leavell S; Porter K; Burkhard MJ
J Infect Dis; 2007 Apr; 195(8):1184-8. PubMed ID: 17357056
[TBL] [Abstract][Full Text] [Related]
42. Feline immunodeficiency virus dendritic cell infection and transfer.
Sprague WS; Robbiani M; Avery PR; O'Halloran KP; Hoover EA
J Gen Virol; 2008 Mar; 89(Pt 3):709-715. PubMed ID: 18272762
[TBL] [Abstract][Full Text] [Related]
43. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK
Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606
[TBL] [Abstract][Full Text] [Related]
44. Lentivirus-induced immune dysregulation.
Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 2008 May; 123(1-2):45-55. PubMed ID: 18289702
[TBL] [Abstract][Full Text] [Related]
45. FIV in cats--a useful model of HIV in people?
Bienzle D
Vet Immunol Immunopathol; 2014 Jun; 159(3-4):171-9. PubMed ID: 24636302
[TBL] [Abstract][Full Text] [Related]
46. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
[TBL] [Abstract][Full Text] [Related]
47. Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.
Carreño AD; Mergia A; Novak J; Gengozian N; Johnson CM
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):161-8. PubMed ID: 17964661
[TBL] [Abstract][Full Text] [Related]
48. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.
Bendinelli M; Pistello M; Lombardi S; Poli A; Garzelli C; Matteucci D; Ceccherini-Nelli L; Malvaldi G; Tozzini F
Clin Microbiol Rev; 1995 Jan; 8(1):87-112. PubMed ID: 7704896
[TBL] [Abstract][Full Text] [Related]
49. Infectivity of lion and puma lentiviruses for domestic cats.
VandeWoude S; O'Brien SJ; Hoover EA
J Gen Virol; 1997 Apr; 78 ( Pt 4)():795-800. PubMed ID: 9129651
[TBL] [Abstract][Full Text] [Related]
50. Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.
Hofmann-Lehmann R; Holznagel E; Ossent P; Lutz H
Clin Diagn Lab Immunol; 1997 Jan; 4(1):33-42. PubMed ID: 9008278
[TBL] [Abstract][Full Text] [Related]
51. Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats.
Dean GA; LaVoy A; Yearley J; Stanton C
J Infect Dis; 2006 Jun; 193(11):1520-7. PubMed ID: 16652280
[TBL] [Abstract][Full Text] [Related]
52. Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats.
Pedersen NC; Leutenegger CM; Woo J; Higgins J
Vet Immunol Immunopathol; 2001 May; 79(1-2):53-67. PubMed ID: 11356250
[TBL] [Abstract][Full Text] [Related]
53. Feline immunodeficiency virus infection of cats as a model to test the effect of certain in vitro selection pressures on the infectivity and virulence of resultant lentivirus variants.
Barlough JE; North TW; Oxford CL; Remington KM; Dandekar S; Ellis MN; Pedersen NC
Antiviral Res; 1993 Dec; 22(4):259-72. PubMed ID: 8279815
[TBL] [Abstract][Full Text] [Related]
54. Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection.
Sellon RK; Jordan HL; Kennedy-Stoskopf S; Tompkins MB; Tompkins WA
J Virol; 1994 May; 68(5):3380-5. PubMed ID: 8151797
[TBL] [Abstract][Full Text] [Related]
55. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
Hosie MJ; Dunsford T; Klein D; Willett BJ; Cannon C; Osborne R; Macdonald J; Spibey N; Mackay N; Jarrett O; Neil JC
J Virol; 2000 Oct; 74(20):9403-11. PubMed ID: 11000209
[TBL] [Abstract][Full Text] [Related]
56. Ability of CD8(+) T cell anti-feline immunodeficiency virus activity correlated with peripheral CD4(+) T cell counts and plasma viremia.
Hohdatsu T; Yamazaki A; Yamada M; Kusuhara H; Kaneshima T; Koyama H
Microbiol Immunol; 2003; 47(10):765-73. PubMed ID: 14605443
[TBL] [Abstract][Full Text] [Related]
57. Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: a direct role for FIV in B-lymphocyte transformation?
Beatty JA; Callanan JJ; Terry A; Jarrett O; Neil JC
J Virol; 1998 Jan; 72(1):767-71. PubMed ID: 9420284
[TBL] [Abstract][Full Text] [Related]
58. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
[TBL] [Abstract][Full Text] [Related]
59. Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
Karlas JA; Siebelink KH; Peer MA; Huisman W; Cuisinier AM; Rimmelzwaan GF; Osterhaus AD
J Gen Virol; 1999 Mar; 80 ( Pt 3)():761-765. PubMed ID: 10092017
[TBL] [Abstract][Full Text] [Related]
60. Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR.
Diehl LJ; Mathiason-DuBard CK; O'Neil LL; Hoover EA
J Virol; 1995 Apr; 69(4):2328-32. PubMed ID: 7533856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
